F.D.A. Analysis Suggests J. & J. Submitted Weak Data for Boosters

The agency said also said that it didn’t have enough time to independently review much of the raw data from the company’s trials.

from NYT > Health https://ift.tt/3lCxZ2I
via health&fitness